Reagents for Nucleic Acid Chemistry
L L • November 24, 2017
Reagents for Nucleic Acid Chemistry
See the full list of in-house Reagents used in our synthesis
Optimized Nucleotide Synthesis
Our nucleotide synthesis is modeled to introduce technical & chemical optimization from start to finish. We achieve that by utilizing our precision arsenal of formulations to aid & improve very specific moments throughout our solid-phase production. Activation, sulfurizing, phosphorylating and capping reagents help add an extra layer of customization to every project we synthesize. NHS Esters enhance affinity and fluorescence and our mono-,di-, triphosphates offer more control to certain chemical reactions.
Reagents for nucleic acid chemistry
| A: Activation Reagents |
|---|
| 1 H -1,2,4-Triazole, (1,2,4-Triazole) |
| 1 H -Imidazole-4,5-dicarbonitrile, (Dicyanoimidazole (DCI)) |
| 5-Benzyl-thio-1-H-tetrazole (BMT) |
| 5-Ethyl-thio-1-H-tetrazole (ETT) |
| Diisopropyl-ammonium-1 H -tetrazolide |
| Dimethoxytrityl-Chloride; DMTr-Chloride |
| Mesitylene Sulphonyl-3-Nitro-1,2,4-Triazole (MSNT)) |
| Monoimethoxytrityl-Chloride; MMTr-Chloride |
| Trimethoxytrityl-Chloride; TMTr-Chloride |
| B: Beaucage Reagents & Sufurizing reagents |
|---|
| Phenylacetyl-Disulfide (PADS) |
| Silanized Bottle (for Beaucage Reagent) |
| DDTT ((Dimethylamino-methylidene)amino)-3 H -1,2,4-dithiazoline-3-thione / Sulfurizing Reagent |
| 3 H -1,2-Benzodithiol-3-one-1,1-dioxide/ Sulfurizing Reagent / Sulfurizing Reagent (Beaucage Reagent) |
| C: Phosphorylating Reagents |
|---|
| Dichloromethoxy-phosphite |
| 2-Cyanoethyl- N , N , N , N -teraisopropylphosphane |
| Bis (diisopropylamino)-chlorophosphine |
| Cyanoethyl-dichlorophosphite |
| Diethoxy- N , N -diisopropyl-phosphoramidite |
| Diethyl-phosphorochloride |
| Ethylene-glycol-morpholino phosphoramidite |
| Methoxy- N , N , N , N -tetraisopropylphosphane |
| N , N -Diisopropylamino-Cyanoethyl phosphonamidic-chloride |
| N , N -Diisopropylamino-methyl-phosphonamidic-chloride |
| N , N -Diisopropyl-methoxy-phosphonamidic-Cl |
| O -Chlorophenyl-phosphorodichloridate |
| P -Ethoxy-Chloro-Reagent |
| D: Nucleoside Synthesis Reagents |
|---|
| 4-Isopropyl-Phenoxy-Acetyl-Chloride |
| Bis-Silyating Reagent |
| E: Sugars, Purines & Pyrimidines |
|---|
| 1,3,5-Tri – O -acetyl-2-deoxy- β -L-ribose |
| 1,3,5-Tri– O -acetyl-2-deoxy- β -D-ribose |
| 1-Alpha-Chloro-3,5-ditoluoyl-2-deoxy- β -D-ribose |
| 1- O -Methyl-2,3,5-tri- O -benzoyl- β -D-ribose |
| 2,3,5- O -Tribenzoyl- β -D-Ribofuranosyl-1-Acetate |
| 2-Deoxy- β -D-ribose |
| 2-Deoxy- β -L-ribose |
| 6-Chloro-7-deaza-Guanine |
| 6-Chloro-7-deaza-Purine |
| 6-Chloro-Guanine |
| 6-Chloro-Purine |
NHS ester/Monophosphate/Diphosphate: NHS esters
| A: Fluorescein |
|---|
| 5-Fluorescein-Dipivalate-NHS Ester (5-FAM Dipivalate NHS Ester)\" |
| 5-Fluorescein-NHS Ester(5-FAM NHS Ester) |
| 6-Fluorescein-Dipivalate-NHS Ester (6-FAM Dipivalate NHS Ester) |
| 6-Fluorescein-NHS Ester (6-FAM NHS Ester) |
| B: Biotin |
|---|
| Biotin-Amido-Caproate- N -Hydroxy |
| Biotin-Ester ( N -Hydroxysuccinimide) |
| Biotin-X-Y-SSE (Biotinamidohexanoyl-amidobutanoyl Succinimidyl ester) |
Monophosphates
| A: Deoxy N -Alkylated monophosphates |
|---|
| N 1 -Methyl-deoxyadenosine-5’-monophosphate |
| N 3 -Methyl-deoxycytidine-5’-monophosphate |
| N 6 -Methyl-deoxyadenosine-5’-monophosphate |
| B: Etheno deoxy & ribo monophosphates |
|---|
| Etheno-deoxycytidine-5’-monophosphate |
| Etheno-ribocytidine-5’-monophosphate |
| C: 7-Deaza deoxymonophosphate |
|---|
| 7-Deaza-deoxyadenosine-5’-monophosphate |
| D: 2’- O -Methyl-ribo monophosphates |
|---|
| 2’- O -Methyl-adenosine ( N 6 -Benzyl)-5’-monophosphate |
| 2’- O -Methyl-cytidine-5’-monophosphate |
| 2’- O -Methyl-guanosine-5’-monophosphate |
| E: β -L-ribo monophosphates |
|---|
| β -L-Adenosine-5’-monophosphate sodium salt |
| β -L-Uridine-5’-monophosphate sodium salt |
| F: 3'-Substituted-ribo monophosphates |
|---|
| 3'-Amino-guanosine-5’-monophosphate |
| 3'-Methyl-guanosine-5’-monophosphate |
| G: ribo monophosphate |
|---|
| Thymidine-5’-monophosphate |
| H: Iso ribo monophosphate |
|---|
| Iso-guanosine ( N -iBu)-5’-monophosphate |
Diphosphates
| A: 2'- O -Methyl ribo 3’,5’-diphosphates |
|---|
| 2'- O -Methyl-adenosine-3’,5’-diphosphate disodium salt |
| 2'- O -Methyl-cytidine-3’,5’-diphosphate disodium salt |
| 2'- O -Methyl-guanosine-3’,5’-diphosphate disodium salt |
| 2'- O -Methyl-uridine-3’,5’-diphosphate disodium salt |
| B: Ribo U 5'-diphoosphates |
| Uridine-5’-diphosphate |
| Uridine-5’-diphosphate disodium salt |
Triphosphates
| A: Etheno deoxy 5’-triphosphates |
|---|
| Etheno-deoxyadenosine-5’-triphosphate disodium salt |
| Etheno-deoxycytidine-5’-triphosphate disodium salt |
| B: 7-Deaza-deoxy 5’-triphosphates |
|---|
| 7-Deaza-deoxyadenosine-5’-triphosphate disodium salt |
| 7-Deaza-deoxyguanosine-5’-triphosphate disodium salt |
| C: Iso deoxy Triphosphate |
|---|
| Iso-deoxyguanosine-5’-triphosphate disodium salt |
| D: 7-Deaza-7-Propargylamine, dideoxy Triphosphates |
|---|
| 7-Deaza-7-propargylamine-2',3'-dideoxyadenosine-5’-triphosphate |
| 7-Deaza-7-propargylamine-2',3'-dideoxyadenosine-5’-triphosphate disodium salt |
| 7-Deaza-7-propargylamine-2',3'-dideoxyguanosine-5’-triphosphate disodium salt |
| E: 5-Propargyl amine-2',3'-Dideoxy Triphosphates |
|---|
| 5-Propargylamine-2',3'-dideoxycytidine-5’-triphosphate |
| 5-Propargylamine-2',3'-dideoxycytidine-5’-triphosphate disodium salt |
| 5-Propargylamine-2',3'-dideoxyuridine-5’-triphosphate disodium salt |
| F: 2',3'-Dideoxy G Triphosphate |
|---|
| 2',3'-Dideoxyguanosine-5’-triphosphate |
| G: 2'- O -Methyl-ribo 5’-triphosphates |
|---|
| 2'- O -Methyl-adenosine-5’-triphosphate disodium salt |
| 2'- O -Methyl-cytidine-5’-triphosphate disodium salt |
| 2'- O -Methyl-guanosine-5’-triphosphate disodium salt |
| 2'- O -Methyl-uridine-5’-triphosphate disodium salt |
| H: Ara-ribo Triphosphates |
|---|
| Ara-adenosine-5’-triphosphate disodium salt |
| Ara-cytidine-5’-triphosphate disodium salt |
| Ara-guanosine-5’-triphosphate disodium salt |
| Ara-uridine-5’-triphosphate disodium salt |
| I: Ara-2'- O -Methyl-ribo Triphosphates |
|---|
| Ara-(2'- O -Methyl)-adenosine-5’-triphosphate disodium salt |
| Ara-(2'- O -Methyl)-cytidine-5’-triphosphate disodium salt |
| Ara-(2'- O -Methyl)-guanosine-5’-triphosphate disodium salt |
| Ara-(2'- O -Methyl)-uridine-5’-triphosphate disodium salt |
| J: Iso ribo triphosphate |
|---|
| Iso-Guanosine-5’-triphosphate disodium salt |
Solvents/Reagents-DNA Synthesis
| A: PolyPlex Oligo-Synthesizer |
|---|
| Acetonitrile Anhydrous (Phosphoramidite Diluent & Washings), PolyPlex Oligonucleotide Synthesizer |
| Acetonitrile Wash Grade,PolyPlex Oligonucleotide Synthesizer |
| Activation Reagent (0.25M 4,5-Dicyanoimidazole/Acetonitrile), PolyPlex Oligonucleotide Synthesizer |
| Activation Reagent (0.25M 5-Ethylthio Tetrazole/Acetonitrile), PolyPlex Oligonucleotide Synthesizer |
| Activation Reagent (0.45M 5-Ethylthio Tetrazole/Acetonitrile), PolyPlex Oligonucleotide Synthesizer |
| Activation Reagent (BMT Solution) (0.3M Benzylthio Tetrazole/Acetonitrile) PolyPlex Oligonucleotide Synthesizer |
| AMA Reagent, PolyPlex Oligonucleotide Synthesizer |
| CAP A (Acetic Anhydride/Pyridine/THF),PolyPlex Oligonucleotide Synthesizer |
| CAP B (10% N -Methylimidazole/THF),PolyPlex Oligonucleotide Synthesizer |
| CAP B (16% N -Methylimidazole/THF), PolyPlex Oligonucleotide Synthesizer |
| DDTT Solution 1 [0.05M] (Sulfurizing Reagent), PolyPlex Oligonucleotide Synthesizer |
| DDTT Solution 1 [0.10M] (Sulfurizing Reagent), PolyPlex Oligonucleotide Synthesizer |
| DMTr Removal Reagent (3% Dichloracetic Acid/Dichloromethane), PolyPlex Oligonucleotide Synthesizer |
| DMTr Removal Reagent (3% Trichloracetic Acid/Dichloromethane), PolyPlex Oligonucleotide Synthesizer |
| Oxidation Solution (0.02M Iodine/Pyridine/H2O/THF), PolyPlex Oligonucleotide Synthesizer |
| Oxidation Solution (0.1M Iodine/Pyridine/H2O/THF), PolyPlex Oligonucleotide Synthesizer |
| Silanized Bottles for Beaucage Reagent, PolyPlex Oligonucleotide Synthesizer |
| Sulfurizing Reagent (Beaucage Reagent) for Introduction of Phosphorothioate (S-oligonucleotide), PolyPlex Oligonucleotide Synthesizer |
| Thiophenol/Triethylamine/Dioxane, PolyPlex Oligonucleotide Synthesizer |
| B: MerMade Oligo-Synthesizer |
|---|
| Acetonitrile Anhydrous (Phosphoramidite Diluent & Washings), MerMade Oligonucleotide Synthesizer |
| Acetonitrile Wash Grade, MerMade Oligonucleotide Synthesizer |
| Activation Reagent (0.25M 4,5-Dicyanoimidazole/Acetonitrile), MerMade Oligonucleotide Synthesizer |
| Activation Reagent (0.25M 5-Ethylthio Tetrazole/Acetonitrile), MerMade Oligonucleotide Synthesizer |
| Activation Reagent (0.45M 5-Ethylthio Tetrazole/Acetonitrile), MerMade Oligonucleotide Synthesizer |
| Activation Reagent (BMT Solution) (0.3M Benzylthio Tetrazole/Acetonitrile) MerMade Oligonucleotide Synthesizer |
| AMA Reagent, MerMade Oligonucleotide Synthesizer |
| CAP A (Acetic Anhydride/Pyridine/THF),MerMade Oligonucleotide Synthesizer |
| CAP B (10% N -Methylimidazole/THF), MerMade Oligonucleotide Synthesizer |
| CAP B (16% N -Methylimidazole/THF), MerMade Oligonucleotide Synthesizer |
| DDTT Solution 1 [0.05M] (Sulfurizing Reagent), MerMade Oligonucleotide Synthesizer |
| DDTT Solution 1 [0.10M] (Sulfurizing Reagent), MerMade Oligonucleotide Synthesizer |
| DMTr Removal Reagent (2.5% Dichloracetic Acid/Dichloromethane), MerMade Oligonucleotide Synthesizer |
| DMTr Removal Reagent (3% Trichloracetic Acid/Dichloromethane), MerMade Oligonucleotide Synthesizer |
| Oxidation Solution (0.02M Iodine/Pyridine/H2O/THF), MerMade Oligonucleotide Synthesizer |
| Oxidation Solution (0.1M Iodine/Pyridine/H2O/THF), MerMade Oligonucleotide Synthesizer |
| Silanized Bottles for Beaucage Reagent, MerMade Oligonucleotide Synthesizer |
| Sulfurizing Reagent (Beaucage Reagent) for Introduction of Phosphorothioate (S-oligonucleotide), MerMade Oligonucleotide Synthesizer |
| Thiophenol/Triethylamine/Dioxane, MerMade Oligonucleotide Synthesizer |
| C: Expedite Oligo-Synthesizer |
|---|
| Acetonitrile Anhydrous (Phosphoramidite Diluent & Washings), Expedite Oligonucleotide Synthesizer |
| Acetonitrile Wash Grade, Expedite Oligonucleotide Synthesizer |
| Activation Reagent (0.25M 4,5-Dicyanoimidazole/Acetonitrile), Expedite Oligonucleotide Synthesizer |
| Activation Reagent (0.25M 5-Ethylthio Tetrazole/Acetonitrile), Expedite Oligonucleotide Synthesizer |
| Activation Reagent (0.45M 5-Ethylthio Tetrazole/Acetonitrile), Expedite Oligonucleotide Synthesizer |
| Activation Reagent (BMT Solution) (0.3M Benzylthio Tetrazole/Acetonitrile) Expedite Oligonucleotide Synthesizer |
| AMA Reagent, Expedite Oligonucleotide Synthesizer |
| CAP A (Acetic Anhydride/Pyridine/THF), Expedite Oligonucleotide Synthesizer |
| CAP B (10% N -Methylimidazole/THF), Expedite Oligonucleotide Synthesizer |
| CAP B (16% N -Methylimidazole/THF), Expedite Oligonucleotide Synthesizer |
| DMTr Removal Reagent (2.5% Dichloracetic Acid/Dichloromethane), Expedite Oligonucleotide Synthesizer |
| DMTr Removal Reagent (3% Trichloracetic Acid/Dichloromethane), Expedite Oligonucleotide Synthesizer |
| Oxidation Solution (0.02M Iodine/Pyridine/H2O/THF), Expedite Oligonucleotide Synthesizer |
| Oxidation Solution (0.1M Iodine/Pyridine/H2O/THF), Expedite Oligonucleotide Synthesizer |
| Silanized Bottles for Beaucage Reagent, Expedite Oligonucleotide Synthesizer |
| Sulfurizing Reagent (Beaucage Reagent) for Introduction of Phosphorothioate (S-oligonucleotide), Expedite Oligonucleotide Synthesizer |
| Thiophenol/Triethylamine/Dioxane, Expedite Oligonucleotide Synthesizer |
| D: Expedite Oligo-Synthesizer |
|---|
| Activator (Benzyl thio tetrazole; 0.2M in acetonitrile) Akta Oligonucleotide Synthesizer |
| Cap A ( N -Methyl imidazole; 20% in Acetonitrile) Akta Oligonucleotide Synthesizer |
| Cap B1 (Acetic Anhydride; 40% (v:v) in Acetonitrile) Akta Oligonucleotide Synthesizer |
| Cap B2 (Symmetrical Collidine; 60% (v:v) in Acetonitrile, Akta Oligonucleotide Synthesizer |
| Deblock (3% DCA in Toluene) Akta Oligonucleotide Synthesizer |
| Oxidizer 4 Liter 50 mM Iodine in 10% Water/Pyridine) Akta Oligonucleotide Synthesizer |
| E: ABI 3900 Oligo-Synthesizer |
|---|
| Acetonitrile Anhydrous (Phosphoramidite Diluent & Washings), ABI 3900 Oligonucleotide Synthesizer |
| Acetonitrile Wash Grade, ABI 3900 Oligonucleotide Synthesizer |
| Activation Reagent (0.25M 4,5-Dicyanoimidazole/Acetonitrile), ABI 3900 Oligonucleotide Synthesizer |
| Activation Reagent (0.25M 5-Ethylthio Tetrazole/Acetonitrile) |
| Activation Reagent (0.45M 5-Ethylthio Tetrazole/Acetonitrile), ABI 3900 Oligonucleotide Synthesizer |
| Activation Reagent (BMT Solution) (0.3M Benzylthio Tetrazole/Acetonitrile) |
| AMA Reagent, ABI 3900 Oligonucleotide Synthesizer |
| CAP A (Acetic Anhydride/Pyridine/THF), ABI 3900 Oligonucleotide Synthesizer |
| CAP B (10% N -Methylimidazole/THF), ABI 3900 Oligonucleotide Synthesizer |
| CAP B (16% N -Methylimidazole/THF), ABI 3900 Oligonucleotide Synthesizer |
| DDTT Solution 1 [0.05M] (Sulfurizing Reagent), ABI 3900 Oligonucleotide Synthesizer |
| DDTT Solution 1 [0.10M] (Sulfurizing Reagent), ABI 3900 Oligonucleotide Synthesizer |
| DMT Removal Reagent (3% Dichloracetic Acid/Dichloromethane), ABI 3900 Oligonucleotide Synthesizer |
| DMT Removal Reagent (3% Trichloracetic Acid/Dichloromethane) |
| Oxidation Solution (0.02M Iodine/Pyridine/H2O/THF), ABI 3900 Oligonucleotide Synthesizer |
| Oxidation Solution (0.1M Iodine/Pyridine/H2O/THF), ABI 3900 Oligonucleotide Synthesizer |
| Silanized Bottles for Beaucage Reagent, ABI 3900 Oligonucleotide Synthesizer |
| Sulfurizing Reagent (Beaucage Reagent) for Introduction of Phosphorothioate (S-oligonucleotide), ABI 3900 Oligonucleotide Synthesizer |
| Thiophenol/Triethylamine/Dioxane, ABI 3900 Oligonucleotide Synthesizer |
| F: ABI Oligo-Synthesizer |
|---|
| Acetonitrile Anhydrous (Phosphoramidite Diluent & Washings), ABI Oligonucleotide Synthesizer |
| Acetonitrile Wash Grade, ABI Oligonucleotide Synthesizer |
| Activation Reagent ((0.25M 5-Ethylthio Tetrazole/Acetonitrile), ABI Oligonucleotide Synthesizer |
| Activation Reagent (0.25M 4,5-Dicyanoimidazole/Acetonitrile), ABI Oligonucleotide Synthesizer |
| Activation Reagent (0.45M 5-Ethylthio Tetrazole/Acetonitrile), ABI Oligonucleotide Synthesizer |
| Activation Reagent (BMT Solution) (0.3M Benzylthio Tetrazole/Acetonitrile), ABI Oligonucleotide Synthesizer |
| AMA Reagent, ABI Oligonucleotide Synthesizer |
| CAP A (Acetic Anhydride/Pyridine/THF), ABI Oligonucleotide Synthesizer |
| CAP B (10% N-Methylimidazole/THF), ABI Oligonucleotide Synthesizer |
| CAP B (16% N-Methylimidazole/THF), ABI Oligonucleotide Synthesizer |
| DMT Removal Reagent (3% Dichloracetic Acid/Dichloromethane), ABI Oligonucleotide Synthesizer |
| DMT Removal Reagent (3% Trichloracetic Acid/Dichloromethane), ABI Oligonucleotide Synthesizer |
| Oxidation Solution (0.02M Iodine/Pyridine/H2O/THF), ABI Oligonucleotide Synthesizer |
| Oxidation Solution (0.1M Iodine/Pyridine/H2O/THF), ABI Oligonucleotide Synthesizer |
| Silanized Bottles for Beaucage Reagent, ABI Oligonucleotide Synthesizer |
| Sulfurizing Reagent (Beaucage Reagent) for Introduction of Phosphorothioate (S-oligonucleotide), ABI Oligonucleotide Synthesizer |
| Thiophenol/Triethylamine/Dioxane, ABI Oligonucleotide Synthesizer |
| G: Solvents/Reagents For H -phosphonate Chemistry |
|---|
| Acetonitrile/Pyridine (50:50), Anhydrous (Diluent for Monomers) |
| Acetonitrile/Pyridine (95:5), Anhydrous (Diluent for Activator) |
| Acetonitrile/Pyridine (wash solvent) |
| Activator for monomers and Capping Reagent (Adamantane catbonyl chloride) |
| Capping for ABI Synthesizers (Isopropyl Phosphite/Acetonitrile/Pyridine) |
| Dipentaflurophenyl Carbonate (Reagent for H-phosphonate) |
| Oxidation Solution 1 (Iodine in Pyridine/H2O/THF) |
| Oxidation Solution 2 (THF/H2O/TEA) |
| H: Deprotection solution for DNA Synthesis |
|---|
| Ammonia Free Oligo Deprotection Solution |
| Deprotection solution for Levulinyl |
Discover kbDNA’s rapid workflow for repurifying rituximab biosimilars to high-purity standards—featuring SEC overlays, gel schematics, and SOPs.
Unfiltered truths, hidden risks, and real data behind life sciences R&D in North America. Discover the facts nobody else is sharing—read the full report now
This article explores the complexities of biosimilars, including their development process, regulatory challenges, economic impact, and future prospects. It highlights the potential of biosimilars to reduce healthcare costs and increase patient access to biologic therapies, providing valuable insights for biopharmaceutical and academic researchers.
